● Single award · contract
Moderna Therapeutics, Inc:advance the Development of an Mrna Vaccine for the Prevention of Zika Virus:
A single federal award, with both ends of the trail linked.
$73M
total award value
2016
action date
94 mo
period
HHSO100201600029C
PIID
Description
Moderna Therapeutics, Inc:advance the Development of an Mrna Vaccine for the Prevention of Zika Virus:: Igf::ot::igf
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceMassachusetts →
CategoryNAICS 541711PSC AN13
Competed?Not recorded✓ from source
Total (exact)$72,965,186
More from Department of Health and Human Services
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
awarded 2022$71.7B
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.